Bromadol, the recently synthetic pain reliever, has peculiar pharmacological characteristics. It primarily works through the partial mu binding site activator, also indicates significant action at the kappa-opioid binding site while well. The combined action produces to a complex profile of consequences, like analgesia, sedation, and potentially